BAYLEE CLARK: Open Payments
NPI 1417728957 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,084 in 145 payments from 34 companies in 2025. Trend: 2023 $0 · 2024 $710 · 2025 $3,084
Food & beverage: $2,984Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $501 |
| Merck Sharp & Dohme LLC | 15 | $292 |
| Novartis Pharmaceuticals Corporation | 13 | $266 |
| ABBVIE INC. | 10 | $229 |
| Incyte Corporation | 9 | $158 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| GlaxoSmithKline, LLC. | 7 | $148 |
| TerSera Therapeutics LLC | 3 | $104 |
| SEAGEN INC. | 1 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
Products named: KEYTRUDA, DARZALEX, ERLEADA, VENCLEXTA, KISQALI, Zoladex, Bard Urinary Drainage Bag, JEMPERLI.
Industry payments across MO — which companies pay providers there.
